These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 38040625)
1. Corrigendum to "Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice." [Biomed. Pharmacother. 150 (2022) 112936]. Zhang D; Ji P; Sun R; Zhou H; Huang L; Kong L; Li W; Li W Biomed Pharmacother; 2024 Jan; 170():115965. PubMed ID: 38040625 [No Abstract] [Full Text] [Related]
2. Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice. Zhang D; Ji P; Sun R; Zhou H; Huang L; Kong L; Li W; Li W Biomed Pharmacother; 2022 Jun; 150():112936. PubMed ID: 35421784 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 Alleviates Lipopolysaccharide-Induced Fibrosis of Endometrial Epithelial Cells in Dairy Cows by Inhibiting Reactive Oxygen Species-Activated NLRP3. Song L; Wang L; Li X; Xiao L Animals (Basel); 2023 Dec; 13(23):. PubMed ID: 38067074 [TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4-MAPK pathway in T2DM mice. Ji P; Shi Q; Liu Y; Han M; Su Y; Sun R; Zhou H; Li W; Li W Ren Fail; 2023 Dec; 45(1):2197075. PubMed ID: 37017270 [TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 ameliorates psoriasis-like skin lesions by suppressing proliferation and NLRP3 inflammasomes in keratinocytes. Mao J; Ma X; Zhu J; Zhang H J Food Biochem; 2022 May; 46(5):e14053. PubMed ID: 35218026 [TBL] [Abstract][Full Text] [Related]
6. Corrigendum to "Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis" [Biomed. Pharmacother. 92 (2017) 962-971]. Mou Z; Huang Q; Chu SF; Zhang MJ; Hu JF; Nai-Hong C; Zhang JT Biomed Pharmacother; 2024 Aug; 177():117034. PubMed ID: 38926051 [No Abstract] [Full Text] [Related]
7. Ginsenoside Rg1 Mitigates Porcine Intestinal Tight Junction Disruptions Induced by LPS through the p38 MAPK/ Kang J; Zhou Y; Zhu C; Ren T; Zhang Y; Xiao L; Fang B Toxics; 2022 May; 10(6):. PubMed ID: 35736894 [TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg1 ameliorates aging‑induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice. Li Y; Zhang D; Li L; Han Y; Dong X; Yang L; Li X; Li W; Li W Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34523690 [TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF-kB/NLRP3 pathway. Luo M; Yan D; Sun Q; Tao J; Xu L; Sun H; Zhao H J Cell Biochem; 2020 Apr; 121(4):2994-3004. PubMed ID: 31709615 [TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg1 alleviates lipopolysaccharide-induced pyroptosis in human periodontal ligament cells via inhibiting Drp1-mediated mitochondrial fission. Chu K; Zhang Z; Chu Y; Xu Y; Yang W; Guo L Arch Oral Biol; 2023 Mar; 147():105632. PubMed ID: 36736069 [TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 alleviates acute liver injury through the induction of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling pathway. Zhao J; He B; Zhang S; Huang W; Li X Int J Med Sci; 2021; 18(6):1382-1389. PubMed ID: 33628094 [No Abstract] [Full Text] [Related]
12. Ginsenoside Rg1 ameliorates sepsis-induced acute kidney injury by inhibiting ferroptosis in renal tubular epithelial cells. Guo J; Wang R; Min F J Leukoc Biol; 2022 Nov; 112(5):1065-1077. PubMed ID: 35774015 [TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice. Han Y; Su Y; Han M; Liu Y; Shi Q; Li X; Wang P; Li W; Li W J Ethnopharmacol; 2023 Feb; 302(Pt A):115923. PubMed ID: 36375645 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages. Bao S; Zou Y; Wang B; Li Y; Zhu J; Luo Y; Li J Int Immunopharmacol; 2015 Sep; 28(1):429-34. PubMed ID: 26122136 [TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 Alleviates Podocyte Injury Induced by Hyperlipidemia via Targeting the mTOR/NF- Wang T; Gao Y; Yue R; Wang X; Shi Y; Xu J; Wu B; Li Y Evid Based Complement Alternat Med; 2020; 2020():2735714. PubMed ID: 33133213 [TBL] [Abstract][Full Text] [Related]
16. Retraction notice to "Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]" [Biomed. Pharmacother. 152 (2022) 113213]. Cao L; Wang S; Zhang L; Li J Biomed Pharmacother; 2023 Apr; 160():114280. PubMed ID: 36725470 [No Abstract] [Full Text] [Related]
17. Ginsenoside Rg1 protects human renal tubular epithelial cells from lipopolysaccharide-induced apoptosis and inflammation damage. Ni XJ; Xu ZQ; Jin H; Zheng SL; Cai Y; Wang JJ Braz J Med Biol Res; 2017 Dec; 51(2):e6611. PubMed ID: 29267498 [TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg1 protects mice against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced liver injury by inhibiting CYP1A1 through the aryl hydrocarbon receptor. Li H; Gao YH; Song L; Chen TF; Zhang GP; Ye ZG; Gao Y; Huo W J Ethnopharmacol; 2022 Aug; 294():115394. PubMed ID: 35595219 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of ginsenoside Rg1 against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway. Ning C; Gao X; Wang C; Huo X; Liu Z; Sun H; Yang X; Sun P; Ma X; Meng Q; Liu K Int Immunopharmacol; 2018 Aug; 61():266-276. PubMed ID: 29902710 [TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 attenuates cerebral ischemia-reperfusion injury through inhibiting the inflammatory activation of microglia. Guan Y; Cao YL; Liu JW; Liu LT; Zheng YJ; Ma XF; Zhai FG Exp Cell Res; 2023 May; 426(1):113552. PubMed ID: 36914061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]